1. Market Research
  2. > Pathology Market Trends
  3. > Autoimmune Disease Industry

Autoimmune Disease Industry Statistics

You might be interested in: Therapy, Pharmaceutical, Hospital, Healthcare, Vaccine, Infectious Disease, Diabetes, Digestive System Disorder, Cancer, Cardiovascular Disease, Hepatitis, HIV AIDS, Blood Disease, Lymphoma, Obesity, Endocrine Disease, Dermatological Condition, Neurological Disorder, Musculoskeletal Disorder, Tuberculosis.

1-7 of 57 reports for Autoimmune Disease

Global Autoimmune Disease Statistics and Therapy Market

  • January 2017
    37 pages
  • Autoimmune Dise...  

    Therapy  

    Hospital  

  • World  

View report >

Autoimmune Disease Statistics in the US

  • March 2018
    4 pages
  • Autoimmune Dise...  

  • United States  

View report >

Autoimmune Disease Statistics

  • February 2017
    10 pages
  • Autoimmune Dise...  

  • Spain  

    Europe  

    South America  

View report >

Autoimmune Disease Statistics in the UK

  • January 2018
    9 pages
  • Autoimmune Dise...  

    Cardiovascular ...  

  • United Kingdom  

View report >

Autoimmune Disease Statistics in Canada

  • July 2017
    6 pages
  • Autoimmune Dise...  

    Therapy  

  • Canada  

    North America  

    Turkey  

View report >

Dermatological Condition and Autoimmune Disease Statistics in Germany

  • January 2018
    106 pages
  • Dermatological ...  

    Autoimmune Dise...  

    Cell Therapy  

  • Germany  

    Europe  

View report >

Autoimmune Disease Statistics in Brazil

  • January 2017
    4 pages
  • Autoimmune Dise...  

  • Brazil  

    United States  

View report >
12 reports for Autoimmune Disease

Purchase Reports From Reputable Market Research Publishers
(From $ 995 - $ 5950)

Biosimilars Market by Product, Manufacturing Type, Disease - Global Forecast to 2023

Biosimilars Market: Global Forecast until 2023

  • $ 5650
  • Industry report
  • April 2018
  • by MarketsandMarkets

The global biosimilars market projected to grow at a CAGR of 31.7% during the forecast period.The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on